Changyoon Baek
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing 5
- Viral gastroenteritis research and epidemiology 4
- Biomedical Engineering top 10%
- Biosensors and Analytical Detection 9
- Graphene and Nanomaterials Applications 5
- Microfluidic and Bio-sensing Technologies 4
- Pharmaceutical Science top 10%
-
- Advanced biosensing and bioanalysis techniques 16
-
- Mosquito-borne diseases and control 3
-
- Neuroscience and Neural Engineering 3
- Co-authors
- Junhong MinMin‐Ho LeeVu Thanh CongSachin Ganpat ChavanAjay Kumar YagatiTaek LeeSung Hee ChungJin‐Ha Choi
- Partner nations
- South KoreaUnited StatesGermany
In The Last Decade
Changyoon Baek
36 papers receiving 599 citations
Peers
Comparison fields: 5 of 93
- Infectious Diseases 120
- Biomedical Engineering 278
- Pharmaceutical Science 30
- Molecular Biology 327
- Electrochemistry 25
Countries citing papers authored by Changyoon Baek
This map shows the geographic impact of Changyoon Baek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyoon Baek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyoon Baek more than expected).
Fields of papers citing papers by Changyoon Baek
This network shows the impact of papers produced by Changyoon Baek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyoon Baek. The network helps show where Changyoon Baek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changyoon Baek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 15 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 64 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 80 | |
| 12 | 2019 | 15 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 5 | |
| 16 | 2016 | 37 | |
| 17 | 2015 | 85 | |
| 18 | 2014 | 39 | |
| 19 | 2014 | 1 | |
| 20 | 2013 | 18 |
About Changyoon Baek
Changyoon Baek is a scholar working on Infectious Diseases, Biomedical Engineering and Molecular Biology, having authored 37 papers that have together received 603 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (16 papers), Biosensors and Analytical Detection (9 papers), SARS-CoV-2 detection and testing (5 papers), Graphene and Nanomaterials Applications (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Microfluidic and Bio-sensing Technologies (4 papers), Mosquito-borne diseases and control (3 papers) and Neuroscience and Neural Engineering (3 papers). The work is most often cited by research in Infectious Diseases (120 citations), Biomedical Engineering (278 citations) and Pharmaceutical Science (30 citations). Changyoon Baek has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Junhong Min, Min‐Ho Lee, Vu Thanh Cong, Sachin Ganpat Chavan, Ajay Kumar Yagati, Taek Lee, Sung Hee Chung, Jin‐Ha Choi, Anna Go and Yeon‐Ju Lee. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.